MHI-TM2000 Linear Accelerator System, Software Version 3.0.0 revision 13 or earlier; Proprietary...

FDA Device Recall #Z-1931-2013 — Class II — June 21, 2013

Recall Summary

Recall Number Z-1931-2013
Classification Class II — Moderate risk
Date Initiated June 21, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm MITSUBISHI HEAVY INDUSTRIES, LTD., HIROSHIMA MACHINERY WORK
Location HIROSHIMA, N/A
Product Type Devices
Quantity 14 (2 in US)

Product Description

MHI-TM2000 Linear Accelerator System, Software Version 3.0.0 revision 13 or earlier; Proprietary and Trade Name: MHI-TM2000/ VERO (TM); Common Name: Medical Linear Accelerator. MHI-TM2000 Linear Accelerator System is intended for radiation therapy of lesions, tumors and conditions anywhere in the body where radiation treatment is indicated

Reason for Recall

Software anomaly: Mitsubishi Heavy Industries, Ltd. became aware of a potential safety issue associated with the VERO (TM) Linear Accelerator System. The VERO (TM) may save treatment delivery record into wrong location under certain conditions.

Distribution Pattern

Worldwide distribution: US (nationwide) including states of TX and FL; and countries of: Belgium, Italy, Japan and Korea.

Lot / Code Information

Serial Numbers #s 201902 and 203901

Other Recalls from MITSUBISHI HEAVY INDUSTRIES, LTD., HI...

Recall # Classification Product Date
Z-1308-2016 Class II VERO MHI-TM2000 Linear Accelerator System --- ... Mar 7, 2016
Z-1244-2016 Class II MHI-TM2000 Linear Accelerator System (Software ... Dec 15, 2015
Z-1574-2015 Class II MHI-TM2000 Linear Accelerator System (Software ... Apr 17, 2015
Z-0821-2015 Class II VERO Linear Accelerator System, Model Number MH... Dec 2, 2014
Z-2653-2014 Class II VERO Linear Accelerator System, Model Number M... Jul 5, 2014

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.